Final CABP and HABP-VABP guidances from FDA; EU seeks to accelerate access to medicines
Dear All, Some regulatory updates today. From FDA, we have final versions of their CABP and HABP-VABP guidance documents. My initial review suggests no big changes: CABP (Community-Acquired Bacterial Pneumonia) The draft from Jan 2014 has been updated with a final version dated June 2020 (link). I generated a comparison between the two (link). The